These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16713027)

  • 1. [Recent advances in the treatment of myelodysplastic syndromes].
    Gelsi-Boyer V; Vey N
    Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents in myelodysplastic syndromes.
    Jabbour EJ; Giles FJ
    Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplasia: when to treat and how.
    Larson RA
    Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes.
    Stankov K; Stankov S; Katanic J
    Curr Pharm Des; 2017; 23(1):135-169. PubMed ID: 27697023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes: the era of understanding.
    Meers S
    Eur J Haematol; 2015 May; 94(5):379-90. PubMed ID: 25186093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes.
    Hofmann WK; Lübbert M; Hoelzer D; Phillip Koeffler H
    Hematol J; 2004; 5(1):1-8. PubMed ID: 14745424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating myelodysplastic syndromes.
    Ryan C; McCann S
    IDrugs; 2005 Apr; 8(4):320-6. PubMed ID: 15800807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndrome hematopoietic stem cell.
    Li J
    Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving treatment options of myelodysplastic syndromes.
    Verbeek W; Ganser A
    Ann Hematol; 2001 Sep; 80(9):499-509. PubMed ID: 11669297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes: From pathogenesis and prognosis to treatment.
    Fenaux P
    Semin Hematol; 2004 Apr; 41(2 Suppl 4):6-12. PubMed ID: 15190510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal sequencing of treatments for patients with myelodysplastic syndromes.
    Itzykson R; Fenaux P
    Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies: hypomethylating agents and beyond.
    Santini V
    Hematology Am Soc Hematol Educ Program; 2012; 2012():65-73. PubMed ID: 23233562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic Syndromes: Diagnosis and Treatment.
    Steensma DP
    Mayo Clin Proc; 2015 Jul; 90(7):969-83. PubMed ID: 26141335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents in myelodysplastic syndromes.
    Jabbour E; Giles FJ
    Curr Hematol Malig Rep; 2006 Mar; 1(1):25-33. PubMed ID: 20425328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.
    Stahl M; Zeidan AM
    Expert Rev Hematol; 2017 Apr; 10(4):345-364. PubMed ID: 28277851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.
    Abou Zahr A; Bernabe Ramirez C; Wozney J; Prebet T; Zeidan AM
    Expert Rev Hematol; 2016; 9(4):377-88. PubMed ID: 26734762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of adult myelodysplastic syndromes.
    Hellström-Lindberg E
    Int J Hematol; 1999 Oct; 70(3):141-54. PubMed ID: 10561906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndromes in adults].
    Beyne-Rauzy O; Laurent G; Adoue D
    Presse Med; 2007 Mar; 36(3 Pt 2):481-91. PubMed ID: 17336857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes--an overview for the practitioner].
    Solenthaler M; Tobler A
    Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.